GARY WEBB: Open Payments
NPI 1063962140 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 84 payments from 17 companies in 2025. Trend: 2023 $1,242 · 2024 $1,297 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $210 |
| ABBVIE INC. | 18 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| Neurocrine BioSciences, Inc. | 7 | $159 |
| E.R. Squibb & Sons, L.L.C. | 10 | $155 |
| Janssen Pharmaceuticals, Inc | 5 | $112 |
| Teva Pharmaceuticals USA, Inc. | 5 | $108 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Biogen, Inc. | 4 | $81 |
| Lundbeck LLC | 4 | $72 |
Products named: CAPLYTA, VRAYLAR, TRINTELLIX, REXULTI, INGREZZA, COBENFY, AUSTEDO XR, ZURZUVAE.
Industry payments across UT — which companies pay providers there.
